AI English summary of an SEC filing — figures as filed
Intuitive Surgical ISRGIntuitive Surgical said total revenue for the 3 months ended June 30, 2025 increased 21% to $2.44 billion from $2.01 billion in the prior-year period. The company cited increases of 18% in instruments and accessories, 28% in systems, and 23% in service.
Key points
AI summaryIntuitive Surgical said total revenue for the 3 months ended June 30, 2025 increased 21% to $2.44 billion from $2.01 billion in the prior-year period. The company cited increases of 18% in instruments and accessories, 28% in systems, and 23% in service.
Intuitive Surgical said it placed 395 da Vinci systems in Q2 2025, up from 341 systems in the prior-year quarter, and the installed base as of June 30, 2025 was approximately 10,488 systems, compared with approximately 9,203 systems a year earlier.
Intuitive Surgical said product gross profit for Q2 2025 increased 18% to $1.36 billion, representing 66.5% of product revenue, but the margin declined from 68.1% in the prior-year quarter. The company cited higher costs associated with the phased launch of its da Vinci 5 system, new tariffs, and increased fixed overhead costs as factors.
Intuitive Surgical said operating cash flow for the 6 months ended June 30, 2025 was $1.30 billion, below net income of $1.37 billion. Inventory increased $494 million in the period, and the company repurchased 0.3 million shares for $181 million.
Key figures
Quarter ended June 30, 2025
- Revenue
- $2.4B
- Operating income
- $743M
- Net income
- $658M
- EPS
- $1.81
- Gross profit
- $1.6B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q2 2025 Total Revenue and Segment Growth Rates
Intuitive Surgical said total revenue for the 3 months ended June 30, 2025 increased 21% to $2.44 billion from $2.01 billion in the prior-year period. The company cited increases of 18% in instruments and accessories, 28% in systems, and 23% in service.
Source · Based on the MD&A text of the filing
da Vinci System Placements and Installed Base
Intuitive Surgical said it placed 395 da Vinci systems in Q2 2025, up from 341 systems in the prior-year quarter, and the installed base as of June 30, 2025 was approximately 10,488 systems, compared with approximately 9,203 systems a year earlier.
Source · Based on the MD&A text of the filing
Q2 Product Gross Profit Margin Decline
Intuitive Surgical said product gross profit for Q2 2025 increased 18% to $1.36 billion, representing 66.5% of product revenue, but the margin declined from 68.1% in the prior-year quarter. The company cited higher costs associated with the phased launch of its da Vinci 5 system, new tariffs, and increased fixed overhead costs as factors.
Source · Based on the MD&A text of the filing
6-Month Operating Cash Flow and Capital Deployment
Intuitive Surgical said operating cash flow for the 6 months ended June 30, 2025 was $1.30 billion, below net income of $1.37 billion. Inventory increased $494 million in the period, and the company repurchased 0.3 million shares for $181 million.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…